The TMPRSS2:ERG Fusion and Response to Androgen Deprivation Therapy for Prostate Cancer

BACKGROUND: In the United States, half of men with prostate cancer harbor the androgen-regulated gene fusion TMPRSS2:ERG. We hypothesized that men with TMPRSS2:ERG positive tumors are more responsive to androgen deprivation therapy (ADT). METHODS: We studied a cohort of 239 men with prostate cancer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Prostate
Päätekijät: Graff, Rebecca E., Pettersson, Andreas, Lis, Rosina T., DuPre, Natalie, Jordahl, Kristina M., Nuttall, Elizabeth, Rider, Jennifer R., Fiorentino, Michelangelo, Sesso, Howard D., Kenfield, Stacey A., Loda, Massimo, Giovannucci, Edward L., Rosner, Bernard, Nguyen, Paul L., Sweeney, Christopher J., Mucci, Lorelei A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4424159/
https://ncbi.nlm.nih.gov/pubmed/25728532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22973
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia